José Manuel Cózar Olmo-rekin lankidetzan egindako argitalpenak (9)

2016

  1. Frequent HLA class I alterations in human prostate cancer: molecular mechanisms and clinical relevance

    Cancer Immunology, Immunotherapy, Vol. 65, Núm. 1, pp. 47-59

2011

  1. Bacillus Calmette-Guerin immunotherapy of bladder cancer induces selection of human leukocyte antigen class I-deficient tumor cells

    International Journal of Cancer, Vol. 129, Núm. 4, pp. 839-846

2010

  1. Higher HLA class i expression in renal cell carcinoma than in autologous normal tissue

    Tissue Antigens, Vol. 75, Núm. 2, pp. 110-118

2006

  1. Analysis of the expression of HLA class I, proinflammatory cytokines and chemokines in primary tumors from patients with localized and metastatic renal cell carcinoma

    Tissue Antigens, Vol. 68, Núm. 4, pp. 303-310

  2. LOH at 6p21.3 region and HLA class altered phenotypes in bladder carcinomas

    Immunogenetics, Vol. 58, Núm. 7, pp. 503-510

2005

  1. Analysis of NK cells and chemokine receptors in tumor infiltrating CD4 T lymphocytes in human renal carcinomas

    Cancer Immunology, Immunotherapy, Vol. 54, Núm. 9, pp. 858-866

  2. Coordinated downregulation of the antigen presentation machinery and HLA class I/β2-microglobulin complex is responsible for HLA-ABC loss in bladder cancer

    International Journal of Cancer, Vol. 113, Núm. 4, pp. 605-610

2003

  1. HLA class I expression in bladder carcinomas

    Tissue Antigens, Vol. 62, Núm. 4, pp. 324-327

2001

  1. A nucleotide insertion in exon 4 is responsible for the absence of expression of an HLA-a*0301 allele in a prostate carcinoma cell line

    Immunogenetics, Vol. 53, Núm. 7, pp. 606-610